Amgen and Allergan ’s anti-cancer biosimilar Mvasi receives FDA approval

The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) for the treatment of five types of cancer.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news